77 related articles for article (PubMed ID: 29208627)
1. A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast cancer.
Baugh AG; Gonzalez E; Narumi VH; Kreger J; Liu Y; Rafie C; Castanon S; Jang J; Kagohara LT; Anastasiadou DP; Leatherman J; Armstrong T; Chan I; Karagiannis GS; Jaffee EM; MacLean A; Torres ETR
Clin Exp Metastasis; 2024 May; ():. PubMed ID: 38717519
[TBL] [Abstract][Full Text] [Related]
2. Immune Milieu Established by Postpartum Liver Involution Promotes Breast Cancer Liver Metastasis.
Bartlett AQ; Pennock ND; Klug A; Schedin P
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916683
[TBL] [Abstract][Full Text] [Related]
3. Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis.
Yang Y; Yang HH; Hu Y; Watson PH; Liu H; Geiger TR; Anver MR; Haines DC; Martin P; Green JE; Lee MP; Hunter KW; Wakefield LM
Oncotarget; 2017 May; 8(19):30621-30643. PubMed ID: 28430642
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Modeling of Mechanics in Cancer Metastasis.
Malandrino A; Kamm RD; Moeendarbary E
ACS Biomater Sci Eng; 2018 Feb; 4(2):294-301. PubMed ID: 29457129
[TBL] [Abstract][Full Text] [Related]
5. Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines.
Morris VL; Tuck AB; Wilson SM; Percy D; Chambers AF
Clin Exp Metastasis; 1993 Jan; 11(1):103-12. PubMed ID: 8422701
[TBL] [Abstract][Full Text] [Related]
6. S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models.
Begg LR; Orriols AM; Zannikou M; Yeh C; Vadlamani P; Kanojia D; Bolin R; Dunne SF; Balakrishnan S; Camarda R; Roth D; Zielinski-Mozny NA; Yau C; Vassilopoulos A; Huang TH; Kim KA; Horiuchi D
Commun Med (Lond); 2024 Feb; 4(1):22. PubMed ID: 38378783
[TBL] [Abstract][Full Text] [Related]
7. Therapy-induced normal tissue damage promotes breast cancer metastasis.
Perkins DW; Steiner I; Haider S; Robertson D; Buus R; O'Leary L; Isacke CM
iScience; 2024 Jan; 27(1):108503. PubMed ID: 38161426
[TBL] [Abstract][Full Text] [Related]
8. Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer Models.
Lambouras M; Roelofs C; Pereira M; Gruber E; Vieusseux JL; Lanteri P; Johnstone CN; Muntz F; O'Toole S; Ooms LM; Mitchell CA; Anderson RL; Britt KL
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982737
[TBL] [Abstract][Full Text] [Related]
9. Age-associated microenvironmental changes highlight the role of PDGF-C in ER
Turrell FK; Orha R; Guppy NJ; Gillespie A; Guelbert M; Starling C; Haider S; Isacke CM
Nat Cancer; 2023 Apr; 4(4):468-484. PubMed ID: 36914817
[TBL] [Abstract][Full Text] [Related]
10. Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies.
Wild SA; Cannell IG; Nicholls A; Kania K; Bressan D; ; Hannon GJ; Sawicka K
Elife; 2022 Dec; 11():. PubMed ID: 36525288
[TBL] [Abstract][Full Text] [Related]
11. Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade.
Jenkins L; Jungwirth U; Avgustinova A; Iravani M; Mills A; Haider S; Harper J; Isacke CM
Cancer Res; 2022 Aug; 82(16):2904-2917. PubMed ID: 35749591
[TBL] [Abstract][Full Text] [Related]
12. Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis.
Jungwirth U; van Weverwijk A; Evans RJ; Jenkins L; Vicente D; Alexander J; Gao Q; Haider S; Iravani M; Isacke CM
Nat Commun; 2021 Jun; 12(1):3516. PubMed ID: 34112782
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer liver metastasis: current and future treatment approaches.
Rashid NS; Grible JM; Clevenger CV; Harrell JC
Clin Exp Metastasis; 2021 Jun; 38(3):263-277. PubMed ID: 33675501
[TBL] [Abstract][Full Text] [Related]
14. Mouse Tumor Models for Advanced Cancer Immunotherapy.
Chulpanova DS; Kitaeva KV; Rutland CS; Rizvanov AA; Solovyeva VV
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32526987
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterisation of two D2A1 mammary cancer sublines to model spontaneous and experimental metastasis in a syngeneic BALB/c host.
Jungwirth U; van Weverwijk A; Melake MJ; Chambers AF; Gao Q; Fivaz M; Isacke CM
Dis Model Mech; 2018 Jan; 11(1):. PubMed ID: 29208627
[TBL] [Abstract][Full Text] [Related]
16. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.
Johnstone CN; Smith YE; Cao Y; Burrows AD; Cross RS; Ling X; Redvers RP; Doherty JP; Eckhardt BL; Natoli AL; Restall CM; Lucas E; Pearson HB; Deb S; Britt KL; Rizzitelli A; Li J; Harmey JH; Pouliot N; Anderson RL
Dis Model Mech; 2015 Mar; 8(3):237-51. PubMed ID: 25633981
[TBL] [Abstract][Full Text] [Related]
17. Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain.
Kijewska M; Viski C; Turrell F; Fitzpatrick A; van Weverwijk A; Gao Q; Iravani M; Isacke CM
Breast Cancer Res; 2019 Jan; 21(1):4. PubMed ID: 30642388
[TBL] [Abstract][Full Text] [Related]
18. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
